Acorah Software Products - Accounts Production 16.8.200 false true 31 March 2024 1 April 2023 false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 13257327 Dr Elijah Behr iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13257327 2024-03-31 13257327 2025-03-31 13257327 2024-04-01 2025-03-31 13257327 frs-core:CurrentFinancialInstruments 2025-03-31 13257327 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13257327 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 13257327 frs-bus:Micro-entities 2024-04-01 2025-03-31 13257327 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13257327 frs-bus:Director1 2024-04-01 2025-03-31 13257327 2023-03-31 13257327 2024-03-31 13257327 2023-04-01 2024-03-31 13257327 frs-core:CurrentFinancialInstruments 2024-03-31
Registered number: 13257327
Behr-Cardiology Limited
Financial Statements
For The Year Ended 31 March 2025
Balance Sheet
Registered number: 13257327
2025 2024
£ £
Fixed assets 550 734
Current assets 56,165 36,227
Creditors: Amounts Falling Due Within One Year (7,810 ) (7,634 )
NET CURRENT ASSETS 48,355 28,593
TOTAL ASSETS LESS CURRENT LIABILITIES 48,905 29,327
NET ASSETS 48,905 29,327
CAPITAL AND RESERVES 48,905 29,327

Notes

1. General Information
Behr-Cardiology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13257327 . The registered office is 53 Oxshott Way,, Cobham, Surrey, KT11 2RU.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Elijah Behr
Director
25 December 2025